Celgene to invest $1 billion in Juno to partner in cancer therapies

(Reuters) - Celgene Corp on Monday launched a 10-year partnership with Juno Therapeutics, announcing a $1 billion investment aimed at bringing to market Juno technologies that harness the immune system to treat cancer and autoimmune diseases.

http://feedproxy.google.com/~r/reuters/healthNews/~3/BxzBTIwLq30/story01.htm

Source: Reuters: Health - June 29, 2015 Category: Consumer Health News Tags: healthNews Source Type: news